206 related articles for article (PubMed ID: 29365091)
1. NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer.
Lécuyer L; Victor Bala A; Deschasaux M; Bouchemal N; Nawfal Triba M; Vasson MP; Rossary A; Demidem A; Galan P; Hercberg S; Partula V; Le Moyec L; Srour B; Fiolet T; Latino-Martel P; Kesse-Guyot E; Savarin P; Touvier M
Int J Epidemiol; 2018 Apr; 47(2):484-494. PubMed ID: 29365091
[TBL] [Abstract][Full Text] [Related]
2. NMR metabolomic profiles associated with long-term risk of prostate cancer.
Lécuyer L; Victor Bala A; Demidem A; Rossary A; Bouchemal N; Triba MN; Galan P; Hercberg S; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Vasson MP; Deschasaux-Tanguy M; Savarin P; Touvier M
Metabolomics; 2021 Mar; 17(3):32. PubMed ID: 33704614
[TBL] [Abstract][Full Text] [Related]
3. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort.
Lécuyer L; Dalle C; Lyan B; Demidem A; Rossary A; Vasson MP; Petera M; Lagree M; Ferreira T; Centeno D; Galan P; Hercberg S; Deschasaux M; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Durand S; Pujos-Guillot E; Touvier M
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1300-1307. PubMed ID: 31164347
[TBL] [Abstract][Full Text] [Related]
4. Diet-Related Metabolomic Signature of Long-Term Breast Cancer Risk Using Penalized Regression: An Exploratory Study in the SU.VI.MAX Cohort.
Lécuyer L; Dalle C; Lefevre-Arbogast S; Micheau P; Lyan B; Rossary A; Demidem A; Petera M; Lagree M; Centeno D; Galan P; Hercberg S; Samieri C; Assi N; Ferrari P; Viallon V; Deschasaux M; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Vasson MP; Durand S; Pujos-Guillot E; Manach C; Touvier M
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):396-405. PubMed ID: 31767565
[TBL] [Abstract][Full Text] [Related]
5. Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort.
Jobard E; Dossus L; Baglietto L; Fornili M; Lécuyer L; Mancini FR; Gunter MJ; Trédan O; Boutron-Ruault MC; Elena-Herrmann B; Severi G; Rothwell JA
Br J Cancer; 2021 May; 124(10):1734-1743. PubMed ID: 33723391
[TBL] [Abstract][Full Text] [Related]
6. Metabolic fingerprinting in breast cancer stages through
Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
[TBL] [Abstract][Full Text] [Related]
7. Plasma carotenoids and retinol and overall and breast cancer risk: a nested case-control study.
Pouchieu C; Galan P; Ducros V; Latino-Martel P; Hercberg S; Touvier M
Nutr Cancer; 2014; 66(6):980-8. PubMed ID: 25072980
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiologic processes have an impact on the plasma metabolomic signature of endometriosis patients.
Vicente-Muñoz S; Morcillo I; Puchades-Carrasco L; Payá V; Pellicer A; Pineda-Lucena A
Fertil Steril; 2016 Dec; 106(7):1733-1741.e1. PubMed ID: 27793377
[TBL] [Abstract][Full Text] [Related]
9. Long-term associations between inflammatory dietary scores in relation to long-term C-reactive protein status measured 12 years later: findings from the Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) cohort.
Julia C; Assmann KE; Shivappa N; Hebert JR; Wirth MD; Hercberg S; Touvier M; Kesse-Guyot E
Br J Nutr; 2017 Jan; 117(2):306-314. PubMed ID: 28166841
[TBL] [Abstract][Full Text] [Related]
10. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.
Touvier M; Fezeu L; Ahluwalia N; Julia C; Charnaux N; Sutton A; Méjean C; Latino-Martel P; Hercberg S; Galan P; Czernichow S
Am J Epidemiol; 2013 Jan; 177(1):3-13. PubMed ID: 23171880
[TBL] [Abstract][Full Text] [Related]
11. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort.
Lécuyer L; Dalle C; Micheau P; Pétéra M; Centeno D; Lyan B; Lagree M; Galan P; Hercberg S; Rossary A; Demidem A; Vasson MP; Partula V; Deschasaux M; Srour B; Latino-Martel P; Druesne-Pecollo N; Kesse-Guyot E; Durand S; Pujos-Guillot E; Manach C; Touvier M
Eur J Nutr; 2020 Dec; 59(8):3425-3439. PubMed ID: 31927670
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
13. Associations between fruit, vegetable and legume intakes and prostate cancer risk: results from the prospective Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) cohort.
Diallo A; Deschasaux M; Galan P; Hercberg S; Zelek L; Latino-Martel P; Touvier M
Br J Nutr; 2016 May; 115(9):1579-85. PubMed ID: 26950824
[TBL] [Abstract][Full Text] [Related]
14. Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?
Richard V; Conotte R; Mayne D; Colet JM
Oncotarget; 2017 Jul; 8(30):49915-49930. PubMed ID: 28611296
[TBL] [Abstract][Full Text] [Related]
15. Combining metabolic profiling of plasma and faeces as a fingerprint of insulin resistance in obesity.
Palomino-Schätzlein M; Mayneris-Perxachs J; Caballano-Infantes E; Rodríguez MA; Palomo-Buitrago ME; Xiao X; Mares R; Ricart W; Simó R; Herance JR; Fernández-Real JM
Clin Nutr; 2020 Jul; 39(7):2292-2300. PubMed ID: 31708234
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.
Zhao H; Shen J; Moore SC; Ye Y; Wu X; Esteva FJ; Tripathy D; Chow WH
Breast Cancer Res Treat; 2019 Aug; 176(3):687-696. PubMed ID: 30771047
[TBL] [Abstract][Full Text] [Related]
17. Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.
Tenori L; Oakman C; Morris PG; Gralka E; Turner N; Cappadona S; Fornier M; Hudis C; Norton L; Luchinat C; Di Leo A
Mol Oncol; 2015 Jan; 9(1):128-39. PubMed ID: 25151299
[TBL] [Abstract][Full Text] [Related]
18. Prospective analysis of circulating metabolites and breast cancer in EPIC.
His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
[TBL] [Abstract][Full Text] [Related]
19. Meeting-in-the-middle using metabolic profiling - a strategy for the identification of intermediate biomarkers in cohort studies.
Chadeau-Hyam M; Athersuch TJ; Keun HC; De Iorio M; Ebbels TM; Jenab M; Sacerdote C; Bruce SJ; Holmes E; Vineis P
Biomarkers; 2011 Feb; 16(1):83-8. PubMed ID: 21114379
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
